406 related articles for article (PubMed ID: 26440515)
1. Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.
Huang CW; Lee MJ; Lee PT; Hsu CY; Huang WC; Chen CL; Chou KJ; Fang HC
PLoS One; 2015; 10(10):e0139886. PubMed ID: 26440515
[TBL] [Abstract][Full Text] [Related]
2. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
[TBL] [Abstract][Full Text] [Related]
3. Serum and dialysate potassium concentrations and survival in hemodialysis patients.
Kovesdy CP; Regidor DL; Mehrotra R; Jing J; McAllister CJ; Greenland S; Kopple JD; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2007 Sep; 2(5):999-1007. PubMed ID: 17702709
[TBL] [Abstract][Full Text] [Related]
4. We Use Dialysate Potassium Levels That Are Too Low in Hemodialysis.
Tucker B; Moledina DG
Semin Dial; 2016 Jul; 29(4):300-2. PubMed ID: 27061895
[TBL] [Abstract][Full Text] [Related]
5. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Karaboyas A; Zee J; Brunelli SM; Usvyat LA; Weiner DE; Maddux FW; Nissenson AR; Jadoul M; Locatelli F; Winkelmayer WC; Port FK; Robinson BM; Tentori F
Am J Kidney Dis; 2017 Feb; 69(2):266-277. PubMed ID: 27866964
[TBL] [Abstract][Full Text] [Related]
6. Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
Jadoul M; Thumma J; Fuller DS; Tentori F; Li Y; Morgenstern H; Mendelssohn D; Tomo T; Ethier J; Port F; Robinson BM
Clin J Am Soc Nephrol; 2012 May; 7(5):765-74. PubMed ID: 22403271
[TBL] [Abstract][Full Text] [Related]
7. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics.
Pun PH; Lehrich RW; Honeycutt EF; Herzog CA; Middleton JP
Kidney Int; 2011 Jan; 79(2):218-27. PubMed ID: 20811332
[TBL] [Abstract][Full Text] [Related]
8. Dialysate content and risk of sudden cardiac death.
Thornley-Brown D; Saha M
Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):557-62. PubMed ID: 26406807
[TBL] [Abstract][Full Text] [Related]
9. Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.
Ferrey A; You AS; Kovesdy CP; Nakata T; Veliz M; Nguyen DV; Kalantar-Zadeh K; Rhee CM
Am J Nephrol; 2018; 47(6):415-423. PubMed ID: 29879714
[TBL] [Abstract][Full Text] [Related]
10. Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study.
Yusuf AA; Hu Y; Singh B; Menoyo JA; Wetmore JB
Am J Nephrol; 2016; 44(3):179-86. PubMed ID: 27592170
[TBL] [Abstract][Full Text] [Related]
11. Potassium kinetics during hemodialysis.
Agar BU; Culleton BF; Fluck R; Leypoldt JK
Hemodial Int; 2015 Jan; 19(1):23-32. PubMed ID: 25091596
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysate potassium and lactate on serum potassium and bicarbonate concentrations during daily hemodialysis at low dialysate flow rates.
Leypoldt JK; Kraus MA; Jaber BL; Weinhandl ED; Collins AJ
BMC Nephrol; 2019 Jul; 20(1):252. PubMed ID: 31288787
[TBL] [Abstract][Full Text] [Related]
13. Postdialysis Hypokalemia and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis.
Ohnishi T; Kimachi M; Fukuma S; Akizawa T; Fukuhara S
Clin J Am Soc Nephrol; 2019 Jun; 14(6):873-881. PubMed ID: 31048327
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE-UTILIZE study.
Agiro A; Duling I; Eudicone J; Davis J; Brahmbhatt YG; Cooper K
Hemodial Int; 2022 Jul; 26(3):397-407. PubMed ID: 35037388
[TBL] [Abstract][Full Text] [Related]
15. Dialysate potassium and risk of death in chronic hemodialysis patients.
Al-Ghamdi G; Hemmelgarn B; Klarenbach S; Manns B; Wiebe N; Tonelli M;
J Nephrol; 2010; 23(1):33-40. PubMed ID: 20091484
[TBL] [Abstract][Full Text] [Related]
16. Outcome and complications of intraoperative hemodialysis during cardiopulmonary bypass with potassium-rich cardioplegia.
Khoo MS; Braden GL; Deaton D; Owen S; Germain M; O'Shea M; Mulhern J; Rousou J; Flack J; Engleman R
Am J Kidney Dis; 2003 Jun; 41(6):1247-56. PubMed ID: 12776278
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
[TBL] [Abstract][Full Text] [Related]
18. Dialysis Prescription and Sudden Death.
Rhee CM; Chou JA; Kalantar-Zadeh K
Semin Nephrol; 2018 Nov; 38(6):570-581. PubMed ID: 30413252
[TBL] [Abstract][Full Text] [Related]
19. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
Lacson E; Wang W; Ma L; Passlick-Deetjen J
Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
[TBL] [Abstract][Full Text] [Related]
20. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
Nephrol Dial Transplant; 2022 Oct; 37(11):2241-2252. PubMed ID: 35793567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
